Ligand‐centered assessment of SARS‐CoV‐2 drug target models in the Protein Data Bank

A bright spot in the SARS‐CoV‐2 (CoV‐2) coronavirus pandemic has been the immediate mobilization of the biomedical community, working to develop treatments and vaccines for COVID‐19. Rational drug design against emerging threats depends on well‐established methodology, mainly utilizing X‐ray crystal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:FEBS J
Autores principales: Wlodawer, Alexander, Dauter, Zbigniew, Shabalin, Ivan G., Gilski, Miroslaw, Brzezinski, Dariusz, Kowiel, Marcin, Minor, Wladek, Rupp, Bernhard, Jaskolski, Mariusz
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7276724/
https://ncbi.nlm.nih.gov/pubmed/32418327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15366
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares